Down syndrome: searching for the genetic culprits

Area of Science:

• Genetics
• Molecular Biology
• Developmental Biology

Background:

• Down syndrome (DS) is a genetic disorder resulting from trisomy of human chromosome 21 (Hsa21).
• DS phenotypes, including cognitive deficits and congenital heart defects, are linked to the overexpression of genes on Hsa21.
• Understanding gene dosage effects is crucial for elucidating DS pathology and developing therapeutic strategies.

Purpose of the Study:

• To identify dosage-sensitive genes on human chromosome 21 responsible for Down syndrome phenotypes.
• To understand the genetic mechanisms underlying the diverse pathologies associated with trisomy 21.
• To provide a foundation for targeted therapies for Down syndrome.

Main Methods:

• Human genetics: analysis of individuals with partial trisomy of Hsa21 to map phenotypic regions.
• Mouse genetics: utilization of engineered mouse models to pinpoint dosage-sensitive genes.
• Comparative genomics to correlate gene dosage with specific phenotypic outcomes.

Main Results:

• Studies have identified specific chromosomal regions on Hsa21 linked to distinct DS phenotypes.
• Engineered mouse models have aided in mapping gene locations and identifying causative genes for certain traits.
• Evidence suggests a complex interplay of multiple genes, each contributing variably to DS pathology.

Conclusions:

• The diverse phenotypes of Down syndrome result from the complex genetic interactions of multiple dosage-sensitive genes on chromosome 21.
• Identifying these genes is essential for understanding the molecular basis of DS and for future therapeutic interventions.
• Further research into gene dosage effects will refine our understanding of trisomy 21 and its associated health conditions.